Vigil (gemogenovatucel-T), using the same principle, is a vaccine based on the ex vivo transfection of autologous carcinoma cells with a short hairpin RNAi combined with the GM-CSF transgene targeting furin to downregulate TGF-β1 and TGF-β2 proteins. This evidence concerns the gene TGFB1 and carcinoma.